An aromatase inhibitor that works to prevent the final step of androgen synthesis, Anastrozole reduces oestrogen levels. As a result, tumours that grow through androgens are inhibited. This is why anastrozole is used in women after menopause with hormone-dependent tumours. It has no androgenic, estrogenic or gestagenic properties.

Formula: C17H19N5

Molecular weight: 293.37 g/mol

Molecular size: Small

Controlled Substance: No

Precursor: No

Indications: Endocrine therapy

Status: Commercial

Axano Pharmaceuticals Ltd
contact us now